Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2017, Article ID 8120689, 3 pages
https://doi.org/10.1155/2017/8120689
Case Report

Anti-Yo Mediated Paraneoplastic Cerebellar Degeneration Associated with Pseudobulbar Affect in a Patient with Breast Cancer

1Department of Surgery, University of Virginia, Charlottesville, VA, USA
2Department of Medicine, University of Virginia, Charlottesville, VA, USA
3Department of Neurology, University of Virginia, Charlottesville, VA, USA

Correspondence should be addressed to Patrick M. Dillon; ude.ainigriv.ccm.liamcsh@b5dmp

Received 6 January 2017; Accepted 23 February 2017; Published 9 March 2017

Academic Editor: Katsuhiro Tanaka

Copyright © 2017 Allison N. Martin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. Fanous and P. Dillon, “Paraneoplastic neurological complications of breast cancer,” Experimental Hematology & Oncology, vol. 5, no. 1, 2015. View at Publisher · View at Google Scholar
  2. R. G. Key and J. C. Root, “Anti-Yo mediated paraneoplastic cerebellar degeneration in the context of breast cancer: a case report and literature review,” Psycho-Oncology, vol. 22, no. 9, pp. 2152–2155, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Ogita, O. H. Llaguna, S. M. Feldman, and R. Blum, “Paraneoplastic cerebellar degeneration with anti-Yo antibody in a patient with HER2/neu overexpressing breast cancer: a case report with a current literature review,” Breast Journal, vol. 14, no. 4, pp. 382–384, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Ahmed and Z. Simmons, “Pseudobulbar affect: prevalence and management,” Therapeutics and Clinical Risk Management, vol. 9, pp. 483–489, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Tiryaki and H. A. Horak, “ALS and other motor neuron diseases,” Continuum (Minneapolis, Minn.), vol. 20, no. 5, pp. 1185–1207, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. J. L. Cummings, D. B. Arciniegas, B. R. Brooks et al., “Defining and diagnosing involuntary emotional expression disorder,” CNS Spectrums, vol. 11, no. 6, pp. 1–7, 2006. View at Google Scholar · View at Scopus
  7. R. Schiffer and L. E. Pope, “Review of pseudobulbar affect including a novel and potential therapy,” Journal of Neuropsychiatry and Clinical Neurosciences, vol. 17, no. 4, pp. 447–454, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. H. S. Wortzel, T. J. Oster, C. A. Anderson, and D. B. Arciniegas, “Pathological laughing and crying: epidemiology, pathophysiology and treatment,” CNS Drugs, vol. 22, no. 7, pp. 531–545, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. V. A. Kumari, P. Gupta, M. V. P. Srivastava, L. Kumar, A. Kriplani, and N. Bhatla, “Araneoplastic cerebellar degeneration as the first evidence of malignancy: a case report,” Journal of Obstetrics and Gynaecology Research, vol. 40, no. 5, pp. 1463–1465, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. J. E. Greenlee, S. A. Clawson, K. E. Hill, B. L. Wood, I. Tsunoda, and N. G. Carlson, “Purkinje cell death after uptake of anti-yo antibodies in cerebellar slice cultures,” Journal of Neuropathology and Experimental Neurology, vol. 69, no. 10, pp. 997–1007, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Gatti, S. Simsek, A. Kurne et al., “Paraneoplastic neurological disorders in breast cancer,” Breast, vol. 12, no. 3, pp. 203–207, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. W.-H. Li, D.-Y. Cao, K. Shen, and J.-X. Yang, “A rare case of ovarian cancer presenting with paraneoplastic cerebellar degeneration and limbic encephalitis,” Chinese Medical Journal, vol. 128, no. 19, pp. 2685–2687, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. D. B. Saeed and L. Gupta, “Paraneoplastic cerebellar degeneration associated with serous adenocarcinoma of the ovary,” BMJ Case Reports, vol. 2014, Article ID 206377, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. M. P. Zaborowski, M. Spaczynski, E. Nowak-Markwitz, and S. Michalak, “Paraneoplastic neurological syndromes associated with ovarian tumors,” Journal of Cancer Research and Clinical Oncology, vol. 141, no. 1, pp. 99–108, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. J. D. Schmahmann and J. C. Sherman, “Cerebellar cognitive affective syndrome,” International Review of Neurobiology, vol. 41, pp. 433–440, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Parvizi, S. W. Anderson, C. O. Martin, H. Damasio, and A. R. Damasio, “Pathological laughter and crying: a link to the cerebellum,” Brain, vol. 124, no. 9, pp. 1708–1719, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Parvizi, D. B. Arciniegas, G. L. Bernardini et al., “Diagnosis and management of pathological laughter and crying,” Mayo Clinic Proceedings, vol. 81, no. 11, pp. 1482–1486, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Parvizi, J. Joseph, D. Z. Press, and J. D. Schmahmann, “Pathological laughter and crying in patients with multiple system atrophy-cerebellar type,” Movement Disorders, vol. 22, no. 6, pp. 798–803, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. A. McKeon, J. A. Tracy, S. J. Pittock, J. E. Parisi, C. J. Klein, and V. A. Lennon, “Purkinje cell cytoplasmic autoantibody type 1 accompaniments: the cerebellum and beyond,” Archives of Neurology, vol. 68, no. 10, pp. 1282–1289, 2011. View at Publisher · View at Google Scholar · View at Scopus